Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 11/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.46 |
| ▸ | CDK4 | P11802 | 9/20 | 0.45 |
| ▸ | CCND1 | P24385 | 9/20 | 0.45 |
| ▸ | CCND2 | P30279 | 9/20 | 0.45 |
| ▸ | CCND3 | P30281 | 9/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.42 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.42 |
| ▸ | CDK1 | P06493 | 2/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.42 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4136624 | 0.86 | CDK4 (0.44) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL19211573 | 0.80 | KCNH2 (0.43) | CYP1A2CDK4CCND1CCND2CCND3 | |
| SCHEMBL19211612 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL19231463 | 0.77 | CYP1A2 (0.62) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL15850811 | 0.75 | CYP1A2 (0.41) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL19211574 | 0.74 | CDK4 (0.44) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL4135768 | 0.74 | CYP1A2 (0.50) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL19250279 | 0.71 | CDK4 (0.41) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 | |
| SCHEMBL20710554 | 0.71 | CDK4 (0.54) | CYP1A2ALDH1A1TSHRCLK4CDK4 | |
| SCHEMBL15850855 | 0.70 | KCNH2 (0.48) | CYP1A2CYP3A4ALDH1A1TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179636-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2021-06-17 | — | — | US | disclosed |
| EP-3414246-A1 | ANTIBACTERIAL COMPOUNDS | Redx Pharma PLC (GB) | 2018-12-19 | — | — | EP | disclosed |
| WO-2017137743-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179636-A1 | ANTIBACTERIAL COMPOUNDS | OXA1L, SYMPK, TBCD | CYP1A2 523/4885CYP3A4 557/4885ALDH1A1 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.